Literature DB >> 32912883

Adult hypophosphatasia manifests in a marathon runner.

Nada Fanous1, Diana Barb2.   

Abstract

A 49-year-old woman, previously healthy, presented with recurrent fractures provoked by minimal trauma. She had sustained seven fractures over the previous 2 years. While she was an avid runner, her injuries were determined to be out of proportion to the degree of trauma. Initial evaluation, exploring the more common causes such as low bone density and abnormal vitamin D metabolism, was unremarkable. On repeat of the some of the tests, a low alkaline phosphatase (AP) was noted, which raised suspicion for hypophosphatasia (HPP), a rare cause of recurrent fractures. Subsequent workup revealed a low bone-specific AP and elevated vitamin B6 Subsequently, genetic testing confirmed the diagnosis of adult-onset HPP caused by a heterozygous mutation c.407G>A in the ALPL gene. Asfotase alfa was started; however, the patient developed an allergic reaction leading to the discontinuation of the drug. © BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  calcium and bone; sports and exercise medicine

Mesh:

Substances:

Year:  2020        PMID: 32912883      PMCID: PMC7482458          DOI: 10.1136/bcr-2020-234764

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  11 in total

1.  Adult hypophosphatasia treated with teriparatide.

Authors:  Michael P Whyte; Steven Mumm; Chad Deal
Journal:  J Clin Endocrinol Metab       Date:  2007-01-09       Impact factor: 5.958

Review 2.  Low serum alkaline phosphatase activity and pathologic fracture: case report and brief review of hypophosphatasia diagnosed in adulthood.

Authors:  Hasnain M Khandwala; Steven Mumm; Michael P Whyte
Journal:  Endocr Pract       Date:  2006 Nov-Dec       Impact factor: 3.443

3.  Five-year efficacy and safety of asfotase alfa therapy for adults and adolescents with hypophosphatasia.

Authors:  Priya S Kishnani; Cheryl Rockman-Greenberg; Frank Rauch; M Tariq Bhatti; Scott Moseley; Andrew E Denker; Eric Watsky; Michael P Whyte
Journal:  Bone       Date:  2018-12-18       Impact factor: 4.398

Review 4.  Hypophosphatasia in Adults: Clinical Assessment and Treatment Considerations.

Authors:  Jay R Shapiro; E Michael Lewiecki
Journal:  J Bone Miner Res       Date:  2017-08-16       Impact factor: 6.741

5.  Enzyme-replacement therapy in life-threatening hypophosphatasia.

Authors:  Michael P Whyte; Cheryl R Greenberg; Nada J Salman; Michael B Bober; William H McAlister; Deborah Wenkert; Bradley J Van Sickle; Jill H Simmons; Terence S Edgar; Martin L Bauer; Mohamed A Hamdan; Nick Bishop; Richard E Lutz; Mairead McGinn; Stanley Craig; Jean N Moore; John W Taylor; Robert H Cleveland; William R Cranley; Ruth Lim; Tom D Thacher; Jill E Mayhew; Matthew Downs; José Luis Millán; Alison M Skrinar; Philippe Crine; Hal Landy
Journal:  N Engl J Med       Date:  2012-03-08       Impact factor: 91.245

6.  Molecular and clinical analysis of ALPL in a cohort of patients with suspicion of Hypophosphatasia.

Authors:  Jair Tenorio; Ignacio Álvarez; Leyre Riancho-Zarrabeitia; Gabriel Á Martos-Moreno; Giorgia Mandrile; Monserrat de la Flor Crespo; Mikhail Sukchev; Mostafa Sherif; Iza Kramer; María T Darnaude-Ortiz; Pedro Arias; Gema Gordo; Irene Dapía; Julián Martinez-Villanueva; Rubén Gómez; José Manuel Iturzaeta; Ghada Otaify; Mayte García-Unzueta; Alessandro Rubinacci; José A Riancho; Mona Aglan; Samia Temtamy; Mohamed Abdel Hamid; Jesús Argente; Víctor L Ruiz-Pérez; Karen E Heath; Pablo Lapunzina
Journal:  Am J Med Genet A       Date:  2017-01-27       Impact factor: 2.802

Review 7.  Hypophosphatasia: An overview For 2017.

Authors:  Michael P Whyte
Journal:  Bone       Date:  2017-02-24       Impact factor: 4.398

8.  Efficacy of anti-sclerostin monoclonal antibody BPS804 in adult patients with hypophosphatasia.

Authors:  Lothar Seefried; Jasmin Baumann; Sarah Hemsley; Christine Hofmann; Erdmute Kunstmann; Beate Kiese; Yue Huang; Simon Chivers; Marie-Anne Valentin; Babul Borah; Ronenn Roubenoff; Uwe Junker; Franz Jakob
Journal:  J Clin Invest       Date:  2017-04-24       Impact factor: 14.808

Review 9.  HYPOPHOSPHATASIA: CLINICAL ASSESSMENT AND MANAGEMENT IN THE ADULT PATIENT-A NARRATIVE REVIEW.

Authors:  Myrian N Vinan-Vega; Ejigayehu G Abate
Journal:  Endocr Pract       Date:  2018-10-05       Impact factor: 3.443

Review 10.  ADULT HYPOPHOSPHATASIA TREATED WITH TERIPARATIDE: REPORT OF 2 PATIENTS AND REVIEW OF THE LITERATURE.

Authors:  Pauline M Camacho; Alaleh M Mazhari; Cory Wilczynski; Ruth Kadanoff; Steven Mumm; Michael P Whyte
Journal:  Endocr Pract       Date:  2016-04-04       Impact factor: 3.443

View more
  1 in total

Review 1.  Vitamin D and Stress Fractures in Sport: Preventive and Therapeutic Measures-A Narrative Review.

Authors:  Beat Knechtle; Zbigniew Jastrzębski; Lee Hill; Pantelis T Nikolaidis
Journal:  Medicina (Kaunas)       Date:  2021-03-01       Impact factor: 2.430

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.